BioCorRx (BICX) EBIT Margin (2011 - 2026)
BioCorRx's EBIT Margin was -445.61% in Q1 2026, up 249.69 percentage points from -695.29% a year earlier.
Powered by 
Analysis
BioCorRx (BICX) EBIT Margin (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, BioCorRx's EBIT Margin was -553.06% through Mar 31, 2026, up 3111.55 percentage points year-over-year; for FY2025, it came in at -606.04%, up 66223.77 percentage points from FY2024.
- EBIT Margin shows a five-year change of +5503.82 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -66829.81% in FY2024 (-62581.50 pp), -4248.31% in FY2023 (-2051.36 pp), -2196.96% in FY2022 (+9217.75 pp) and -11414.71% in FY2021 (-5304.84 pp).
- Quarterly EBIT Margin has moved between -33852.95% (Q2 2024) and -306.28% (Q3 2025) over five years.
- Compared with a year earlier, EBIT Margin was higher in three of the last four quarters, with an average year-over-year change of +7585.77 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q2 2025 (a gain of 33059.68 percentage points); the worst was Q2 2024 (a drop of 29030.44 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | BioCorRx | 3.46 Mn | 2.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -445.61% |
| Sep 30, 2025 | -306.28% |
| Jun 30, 2025 | -793.28% |
| Mar 31, 2025 | -695.29% |
| Jun 30, 2024 | -33,852.95% |
| Mar 31, 2024 | -26,759.45% |
| Dec 31, 2023 | -4,344.24% |
| Sep 30, 2023 | -9,481.20% |
| Jun 30, 2023 | -4,822.52% |
| Mar 31, 2023 | -2,611.93% |
| Dec 31, 2022 | -1,430.79% |
| Sep 30, 2022 | -1,089.70% |
| Jun 30, 2022 | -8,488.66% |
| Mar 31, 2022 | -5,481.40% |
| Dec 31, 2021 | -9,790.91% |
| Sep 30, 2021 | -18,539.74% |
| Jun 30, 2021 | -6,129.32% |
| Mar 31, 2021 | -15,598.74% |
| Dec 31, 2020 | -7,952.62% |
| Sep 30, 2020 | -6,886.71% |
API Access
BioCorRx EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();